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The gold standard for treatment of upper urinary tract urothelial carcinoma remains nephroureter-
ectomy with the ipsilateral bladder cuff excision. With the introduction of robot system, robot-assisted
surgery has become popular in the management of urological malignancies. We report a single institute
experience of robot-assisted nephroureterectomy (RANU) for the treatment of upper urinary tract uro-
thelial carcinoma (UC) without re-docking the robot system or reposition of the patient. The perioper-
ative and oncologic outcomes are discussed.
Copyright © 2015, Taiwan Urological Association. Published by Elsevier Taiwan LLC. This is an open access
article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
The gold standard for treatment of upper urinary tract urothelial
carcinoma is nephroureterectomy with ipsilateral bladder cuff
excision. Laparoscopic nephroureterectomy was ﬁrst reported by
Clayman et al1 in 1991, and since then, it has been shown to have
comparable oncologic outcomes when compared with the open
method, with the additional advantages of shorter length of hos-
pital stay, decreased blood loss, and decreased analgesic use.2e6 The
most challenging part during laparoscopic nephroureterectomy is
management of the distal ureter and excision of the bladder cuff
with subsequent bladder reconstruction. Although many tech-
niques have been described for bladder cuff management, there is
no consensus regarding the most effective and suitable approach.
With the introduction of the da Vinci robot system (Intuitive
Surgical, Sunnyvale, CA, USA), robot-assisted surgery has become
popular in themanagement of urological malignancies. Because the
robotic system features facilitating intracorporeal suturing, it has
thus been applied successfully to nephrectomy and
prostatectomy7e9. We report a case series regarding robot-assisted
nephroureterectomy for upper urinary tract urothelial carcinomaulevard Section 4, Taichung
ociation. Published by Elsevier Ta(UC) without redocking the robot system or repositioning of the
patient. We also provide perioperative and oncologic outcomes.
2. Materials and methods
From December 2010 to December 2012, a retrospective chart
reviewwas performed at the Taichung Veterans General Hospital to
identify patients undergoing robot-assisted nephroureterectomy
(RANU) for the treatment of upper urinary tract UC. All operations
were performed by a surgeon (Y. C. Ou). Preoperative staging ex-
amination and evaluation were completed, including history tak-
ing, physical examination, cystoscopy to exclude bladder invasion,
and image study using computer tomography (CT scan) ormagnetic
resonance imaging (MRI) to rule out metastatic lesion. Patients'
demographics, operative parameters, complications, and oncologic
outcomes were collected and analyzed.
2.1. Surgical technique
Under general endotracheal anesthesia, patients were placed in
a modiﬁed ﬂank position. The diseased side was kept upright and a
15 degree slight Trendelenburg position was performed. The
operating table was ﬂexed appropriately. Robotic ports placement
is shown in Fig. 1. A small incision at the periumbilicus region was
made and a 12-mm camera port was positioned. Pneumo-
peritoneum of 15 mmHg CO2 was created. Three 8-mm da Vinciiwan LLC. This is an open access article under the CC BY-NC-ND license (http://
Fig. 1. Ports placement for robotic assisted right-side nephroureterectomy.
Table 1
Patient demographics and tumor characteristics.
Variables N (%) or mean (range)
No. of patients 13
Sex (M:F) 7:6
Mean age (y) 72 (range 48e91)
Side, n, (R:L) 7:6
Mean operation time (min) 129 (105e150)
Mean EBL (mL) 128 (30e500)
Mean postop hospital stay (d) 7 (4e14)
ASA classiﬁcation
I 0 (0)
II 9 (69)
III 4 (31)
IV 0 (0)
Mean BMI 23.7 (16e29)
Complications 2 (15)
Tumor location
Pelvicalyceal 8 (61)
Ureteral 4 (30)
Pelvicalycealeureteral 1 (7)
ASA ¼ The American Society of Anesthesiologists; BMI ¼ body mass index;
EBL ¼ estimated blood loss; F ¼ female; L ¼ left; M ¼ male; R ¼ right.
Table 2
Pathological characteristics of RANU patients.
Variables N (%) or mean (range)
Tumor stage
Ta 1 (8)
T1 3 (23)
T2 2 (15)
T3 6 (46)
G.-S. Lai et al. / Urological Science 27 (2016) 174e176 175ports were placed. The ﬁrst 8-mm port was ~8 cm cranial to the
camera port and the second 8-mm port was placed ~8 cm lateral to
the camera port. The ﬁrst and second 8-mm ports were ~8 cm apart
from each other and a triangle shapewas formed by the ﬁrst 8-mm,
second 8-mm, and camera ports. One 12-mm assistant port was
placed ~4 cm cranial to the camera port. The third 8-mm port was
placed ~8 cm caudal to the camera port. Da Vinci was docked to-
ward the patient's back and perpendicular to the patient. A zero
degree lens laparoscopy camera was used. The ﬁrst 8-mm robotic
port used the right arm with monopolar curved scissors. The sec-
ond 8-mm robotic port used the left arm with Maryland bipolar
forceps. A ProGrasp forceps (Intuitive Surgical, Sunnyvale, CA, USA)
was used to help maintain traction through the assisting port.
Dissection of the colon was performed for mobilization. The ureter
was identiﬁed and dissected cranially to the renal hilum. A hemo-
lock clip was placed on the ureter to prevent downward spillage of
malignant cells. The renal pedicle was identiﬁed, and the renal
artery, vein, and gonadal vein were dissected and ligated using an
endoscopic stapler. The kidney was dissected completely and the
ureter was dissected to the level of the iliac vessels.
After completing nephrectomy and lymphadenectomy, a 30-
degree down lens laparoscopy camera was used and directed to-
ward the bladder. The third 8-mm robotic port was used for the left
arm with Maryland bipolar forceps. The second robotic port was
used for the right hand with monopolar scissors. ProGrasp forceps
were placed at the ﬁrst robotic port. Dissection of the peritoneum
around the lower ureter and lateral urinary bladder wall was per-
formed. The urethral Foley catheter was clamped to let the urinary
bladder distend and facilitate extravesical bladder cuff excision.
After completing bladder cuff excision, the bladder defect was
repaired in two layers using 3-0 vicryl sutures. Normal saline in-
jection through the urethral Foley catheter was performed to test
the integrity of the urinary bladder. The specimen, including the
kidney and ureter, were removed from the extended umbilical
wound.T4 1 (8)
Grade
High 11 (85)
Low 2 (15)
Surgical margins
Positive 3 (23)
Negative 10 (77)
Lymph nodes
Positive 2
Negative 4
Not performed 7
Mean follow up (mo) 14 (1e38)
Recurrence
Bladder recurrence 2 (16)
Local/retroperitoneal 0 (0)
Distant metastasis 2 (15)
RANU ¼ robot-assisted nephroureterectomy.3. Results
Patient characteristics and perioperative data are shown in
Table 1. In all, 13 patients receiving an operation by a surgeon from a
single institute were analyzed. The mean (range) age was 72
(48e91) years. The mean operating time was 129 (105e150) mi-
nutes. The mean (range) estimated blood loss was 128 (30e500)
mL. The mean (range) length of hospital stay was 7 (4e14) days.
There were two postoperative complications: pneumonia and
brachial nerve injury. The pathology reports are summarized in
Table 2. All of the 13 patients had a pathology diagnosis of uro-
thelial carcinoma. Two patients had low grade tumors and the
other 11 patients had high grade tumors. Ta tumor was seen in onepatient, T1 in three patients, T2 in two patients, T3 in six patients,
and T4 in one patient. Lymph node dissection was performed in six
(46%) patients with two patients having positive lymph node
involvement. Patients with advanced tumors underwent adjuvant
chemotherapy. Adjuvant chemotherapy was given to six patients
with pT3 tumors and to one patient with a pT4 tumor. The mean
(range) follow up was 14 (1e38) months. During the postoperative
surveillance, two patients with a high grade pT3 tumor developed
urinary bladder recurrence and two patients with high grade pT3
disease had distant metastasis (brain and lung metastasis).
4. Discussion
For the treatment of upper urinary tract UC, nephroureter-
ectomy with ipsilateral bladder cuff excision remains the gold
standard. With the introduction of the da Vinci robot system, this
robot-assisted surgery has rapidly expanded in the ﬁeld of uro-
logical malignancies. Robotic-assisted prostatectomy has been
accepted and developed as an effective method of treatment with
G.-S. Lai et al. / Urological Science 27 (2016) 174e176176good oncologic outcomes for prostate cancers.10 Robot-assisted
surgery can also be applied to the management of other urologi-
cal diseases, such as kidney or bladder disease.11e13
For RANU with bladder cuff excision, the most challenging part
of the procedure was management of the distal ureter and bladder
cuff. This difﬁculty was magniﬁed for patients with an increased
body mass index or deep and narrow pelvic cavity. The robotic
assisted surgical system provided three-dimensional and magni-
ﬁed vision that mimics the open method. Because of its increased
range of motion and improved access for intracorporeal suture, the
da Vinci robotic system could be applied to the management of
distal ureter and bladder cuff.
A few case series listed in Table 3 describe the complete robotic
approach for nephroureterectomy and bladder cuff excision.
Comparedwith the case series of Park et al14 and Eandi et al15,which
involved redocking the robot system or repositioning of the patient
or patient cart during the operation, our method does not require
intraoperative redocking or repositioning and, therefore, has a
shorter operation time. Hemal et al16 and Pugh et al17 reported a
case series involving a robotic approach for nephroureterectomy
and bladder cuff excision without redocking or repositioning. The
present series has comparable perioperative outcomes with shorter
operating times and similar estimated blood loss when compared
with the previous studies listed in Table 3. Hospital stays were
longer in the present series, which may probably be attributed to
different practice patterns between different countries.
There were two cases of operation complications. One patient
with end stage renal disease under hemodialysis experienced res-
piratory failure after the operation because of pulmonary edema.
Endotracheal tube intubation was performed and weaning the
endotracheal tube was successful after 4 days of antibiotic treat-
ment and proper ﬂuid management. This emphasized the impor-
tance of ﬂuid control during the operation for patients with poor
renal function which was more prevalent in patients with urinary
tract UC. The other patient had brachial nerve palsy after the
operation, which resolved spontaneously 6 months later. This
demonstrated that good positioning of the patient with all pressure
points being padded properly was important to prevent nerve
injury or pressure sores.
Two patients experienced urinary bladder recurrence and two
patients developed distant metastasis during postoperative sur-
veillance. All of the four patients had high-grade pT3 tumors. Pa-
tients with urinary bladder recurrence received transurethral
resection of the bladder tumor. Two patients with distant metas-
tasis died from brain metastasis and suffocation. Our results indi-
cate that tumor stage and grade are important prognostic factors
regarding outcomes after operations.
Three patients had positive margins over bladder cuff. All of
them had bladder UC before which was conﬁrmed by the cystos-
copy. This would probably contribute to the positive margin in the
present series.
Several limitations exist in the present series. The present study
was a retrospective case series with a small sample size and
therefore, only limited results could be concluded from our series.Table 3
Comparison of complete robotic assisted RANU procedures.
Reference Case no. Operation
time (min)
Estimated blood
loss (mL0
Hospital
stay (d)
Park et al14 11 247 106 7
Eandi et al15 11 326 200 5
Hemal et al16 15 184 103 3
Pugh et al17 43 249 133 3
Present series 13 129 128 7
RANU ¼ robot-assisted nephroureterectomy.Furthermore, the present case series, although it had a good
oncologic outcome, had short-term postoperative surveillancewith
a mean follow up of ~14 months. A larger prospective randomized
control study with long-term follow up is needed to determine the
most feasible and suitable approach for nephroureterectomy and
bladder cuff excision.
5. Conclusion
The robotic procedure without intraoperative repositioning of
the patient or redocking of the robot for the treatment of upper
urinary tract UC described here, indicates that RANU is a feasible
approach. Perioperative and short-term oncologic outcomes were
comparable with other series of robotic assisted techniques.
Further study with a larger number of patients and long-term
follow up are needed in order to evaluate the role of the procedure.
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